Concepedia

Magnus Brisander

MB

Statistics

Publications

11

Citations

301

H-Index

11

Active since

1997

Affiliations

Uppsala University(Current)

Stockholm University

AstraZeneca (Sweden)

Acadia Pharmaceuticals (United States)

UiT The Arctic University of Norway

Magnus Brisander is an author at Uppsala University specializing in medicinal chemistry, pharmacology, and neuropharmacology.

ORCID

Publications per year

1997–2024

11

Publications

11

Diastereoselective Reduction of a Chiral <i>N</i>-Boc-Protected δ-Amino-α,β-unsaturated γ-Keto Ester Phe-Gly Dipeptidomimetic

Jon Våbenø, Magnus Brisander, Tore Lejon et al. · The Journal of Organic Chemistry · 2002 · 46 citations

, , +12

HIV-1 Protease Inhibitors Based on Acyclic Carbohydrates

Guido Zuccarello, Abderrahim Bouzide, Ingemar Kvarnström et al. · The Journal of Organic Chemistry · 1998 · 44 citations

, , +10

Carbon Dioxide-Mediated Generation of Hybrid Nanoparticles for Improved Bioavailability of Protein Kinase Inhibitors

Gérald Jesson, Magnus Brisander, Per Andersson et al. · Pharmaceutical Research · 2013 · 41 citations · Full text

, , +17

Atropisomeric Derivatives of 2‘,6‘-Disubstituted (<i>R</i>)-11-Phenylaporphine:  Selective Serotonin 5-HT<sub>7</sub> Receptor Antagonists

Tero Linnanen, Magnus Brisander, Lena Unelius et al. · Journal of Medicinal Chemistry · 2001 · 40 citations · Full text

, , +14

Matrix effects in nilotinib formulations with pH-responsive polymer produced by carbon dioxide-mediated precipitation

Stefano Colombo, Magnus Brisander, Jakob Haglöf et al. · International Journal of Pharmaceutics · 2015 · 27 citations

, , +17

1–5 of 11